Researchers will re-examine "failed" cancer treatment

04/19/2013 | Nature (free content)

Researchers with the National Cancer Institute are re-examining failed clinical trials in an effort to learn why some cancer patients appear to still benefit from the trial drugs. Scientists will particularly ask for personal accounts, tissue samples and research data related to a new drug type called farnesyltransferase inhibitors. "It's time for us to stop just collecting anecdotes and dive deeper," said oncologist Gerald Batist.

View Full Article in:

Nature (free content)

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
Master Educator
DC Public Schools
Washington, DC
District Superintendent
Department of Defense Education Activity (DoDEA)
Partner - Strategy, Systems and Policy
Nationwide, SL_Nationwide
Professional Development Manager (West Coast residence preferred)
Rowland Reading Foundation
Nationwide, SL_Nationwide
Deputy Director for Curriculum, Instruction & Assessment
Department of Defense Education Activity (DoDEA)